患有和没有艾滋病毒的移植捐赠者之间的炎症:多中心HOPE in Action联盟
Fatima Zaman1, Xianming Zhu1, Joanne H Hunt2
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Clinical immunology (Orlando, Fla.)
|July 13, 2025
概括
患有艾滋病毒的脏捐赠者与没有艾滋病毒的脏捐赠者相比,具有类似或较低的炎症概况. 这支持使用艾滋病毒阳性捐赠者进行脏移植的安全性,提高了器官的可用性.
科学领域:
- 移植免疫学 移植免疫学
- 传染病研究传染病研究.
背景情况:
- 从携带人类免疫缺陷病毒 (HIV) 的捐赠者获得移植现在是标准的做法.
- 这些捐赠者的炎症特征需要进行彻底的表征.
研究的目的:
- 为了比较患有艾滋病毒和没有艾滋病毒的脏捐赠者之间的血细胞因子和化学因子水平.
- 评估HIV阳性脏捐赠者的炎症状况.
主要方法:
- 分析了63名艾滋病毒阳性和41名艾滋病毒阴性脏捐赠者的32种细胞因子和化学因子.
- 使用威尔科克森等级总和测试进行跨组比较.
- 与CD4计数和HIV病毒载荷相关的细胞因子水平.
主要成果:
- 大多数细胞因子和化学因子水平在捐赠组之间是相似的.
- 在没有艾滋病毒的捐赠者中,介质素-8 (IL-8) 水平显著更高 (p < 0.0015).
- 在细胞因子水平和CD4计数或HIV病毒载量之间没有发现显著的相关性.
结论:
- 患有艾滋病毒的脏捐赠者的炎症概况与没有艾滋病毒的脏捐赠者的炎症概况相似或更低.
- 这些发现支持艾滋病毒阳性捐赠者的移植的安全性.
- 这种做法有可能改善移植的存活率和器官的可用性.
关键词:
化学因子 (chemokines) 是一种化学物质.细胞因子 (cytokines) 是一种细胞因子.艾滋病病毒 艾滋病病毒 艾滋病病毒"希望法案"就是希望法案.炎症 炎症是一种炎症.脏 脏是指脏.器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐赠器官捐献器器官移植 器官移植 器官移植移植 移植 移植 移植相关概念视频
Kidney Transplant I: Introduction
64
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
64
Kidney Transplant II: Surgical Procedure
77
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
77
Kidney Transplant III: Nursing Management
83
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
83
Acute Kidney Injury IV: Diagnostic Studies and Prevention
58
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
58
Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524
Acute Kidney Injury III: Clinical Manifestations
96
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
96


